Table 3.

Correlations of FPGS, FPGH, and the Ratio FPGS/FPGH with MTX Accumulation and Polyglutamylation Data in Childhood Leukemia Samples

c/preB-ALL3-150T-ALL3-151AML3-152c/preB-, T-ALL, and AML
acc. Glu1-6racc. Glu4-6racc. Glu1-6racc. Glu4-6racc. Glu1-6racc. Glu4-6racc. Glu1-6racc. Glu4-6r
Normalized to cell number  
 FPGS  .623-154 .493-153 .31  −.03  .60  .20  .673-154 .493-154 
 FPGH  .12  .28  −.03  −.45  .18  .08 −.04  −.343-153 
 FPGS/FPGH  .553-153 .27  .71 .70  .60  .02  .633-154 .613-154 
Normalized to mg protein  
 FPGS  .583-154 .593-153 .04  −.37  .60 .33  .573-154 .563-154 
 FPGH  .10  .27  −.15 −.53  −.04  .08  −.06  −.21  
 FPGS/FPGH .533-153 .30  0  .70  .55  .17  .523-154 .673-154 
c/preB-ALL3-150T-ALL3-151AML3-152c/preB-, T-ALL, and AML
acc. Glu1-6racc. Glu4-6racc. Glu1-6racc. Glu4-6racc. Glu1-6racc. Glu4-6racc. Glu1-6racc. Glu4-6r
Normalized to cell number  
 FPGS  .623-154 .493-153 .31  −.03  .60  .20  .673-154 .493-154 
 FPGH  .12  .28  −.03  −.45  .18  .08 −.04  −.343-153 
 FPGS/FPGH  .553-153 .27  .71 .70  .60  .02  .633-154 .613-154 
Normalized to mg protein  
 FPGS  .583-154 .593-153 .04  −.37  .60 .33  .573-154 .563-154 
 FPGH  .10  .27  −.15 −.53  −.04  .08  −.06  −.21  
 FPGS/FPGH .533-153 .30  0  .70  .55  .17  .523-154 .673-154 
F3-150

Number of c/preB-ALL samples were ranging from 16 to 37.

F3-151

Number of T-ALL samples were ranging from 5 to 12.

F3-152

Number of AML samples were ranging from 8 to 13.

F3-153

Significance at the level of 0.05 (two-tailed).

F3-154

Significance at the level of 0.01 (two-tailed).

or Create an Account

Close Modal
Close Modal